Company UpdateNewspaper Publication
HealthcarePharmaceuticals & BiotechnologyPharmaceuticals
Sunil Healthcare Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 23 filings·Updated 21 Aug 2026
Showing 10 of 23 filings.
21 Aug 20261 filing
15 Aug 20261 filing
Company UpdateNewspaper Publication
Copy of Newspaper publication of Un-audited financial results (both standalone and consolidated) for the quarter ended 30th June 2026
13 Aug 20261 filing
Board MeetingOutcome of Board Meeting
Sunil Healthcare approves unaudited Q1 FY2026-27 results, AGM arrangements, and tax deferral option.
Financial results
- Unaudited standalone and consolidated results approved for quarter ended June 30, 2026.
e-voting and scrutiny providers
- MUFG InTime India Pvt. Ltd appointed for remote e-voting and VC for 52nd AGM on Sep 28, 2026.
- ATCS & Associates appointed as Scrutinizer for AGM e-voting.
AGM timing and book closure
- Book closure from 22.09.2026 to 28.09.2026 for AGM.
- Ensuing AGM fixed for Sep 21, 2026 via VC/AVM; cut-off date set for Sep 21, 2026.
Tax matters
- Exercising Section 200 IT Act option for deferred tax on gain from fair valuation; net changes recognized.
Auditor reviews
- Independent auditor's review reports on standalone and consolidated results; no material misstatement identified.
31 Jul 20261 filing
Board Meeting
Sunil Healthcare to consider unaudited standalone and consolidated Q1 FY2026-27 results on Aug 13, 2026; trading window closed.
Meeting Details
- Aug 13, 2026; venue: 38E/252A, Vijay Tower, Shahpur Jat, New Delhi; via video conferencing.
Key Agenda Items
- Consider and approve unaudited standalone and consolidated Q1 FY2026-27 financial results for the quarter ended June 30, 2026.
Other Notes
- Trading window to remain closed from July 1, 2026 to August 15, 2026 (inclusive).
6 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dematerialisation completed; securities listed on exchanges; depository updated as registered owner
Dematerialisation outcome
- Dematerialisation completed; certificates mutilated and cancelled, depository updated as registered owner.
- Securities dematerialised listed on the stock exchanges.
30 Jun 20261 filing
Company UpdateGeneral
Special window opened for transfer and demat of pre-2019 physical shares
Physical share demat window
- One-year window for transfer and demat of pre-2019 physical shares, 5 Feb 2026 to 4 Feb 2027.
- Eligible investors are holders before 1 April 2019 who meet transfer criteria.
- Dematted shares will be locked-in for one year; no transfer, lien, or pledge allowed.
- Disputes and IE PF transfers are excluded from the window.
- Transfers must follow SEBI circular referenced for the window.
- Applies to investors who sold or purchased physical securities before 1 April 2019.
- Submit Original Certificates, Transfer Deed, CML, and documents to Alankit RTA or the company.
- RTA is M/s Alankit Assignment Limited; contact lalitap@alankit.com or rta@alankit.com; cs@sunilhealthcare.com.
- Info also available on the Sunil Healthcare website.
- This update is information for record; no guaranteed final action.
31 May 20261 filing
Company UpdateNewspaper Publication
Copy of newspaper publication dated 31.05.2026 of the financial results for the quarter/year ended 31.03.206
30 May 20261 filing
Company UpdateReg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial year 2025-26
19 May 20261 filing
Board Meeting
Sunil Healthcare Ltd - 537253 - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 29.05.2026 Through Video Conferencing/Audio Visual Connection, Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Meeting Details
- Board meeting scheduled for 29 May 2026.
- Meeting time not disclosed.
- Deemed venue: Registered office, 38E/252A, Vijay Tower, Shahpur Jat, New Delhi-110049.
- Meeting to be held through video conferencing/audio visual connection.
Key Agenda Items
- Approve and take on record audited standalone and consolidated financial results.
- Results cover Q4 FY2025-26 and financial year ended 31 March 2026.
Other Notes
- Trading window remains closed from 1 April 2026 to 31 May 2026, both days inclusive.
24 Apr 20261 filing
OthersFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Showing 10 of 23 filings